David Sans of New York, FAARM, Ph.D., M.B.A., is a Chemical Engineer with a PhD in Chemometrics and Artificial Intelligence from Dr. Stoessel's group at the ETH Zurich and a Mount Sinai Board Certification in Cell Therapies. David holds FINRA Series 7, 63, 15, and 55 licenses in Healthcare Investment Banking. David has over 12 years of experience in healthcare investment banking, where he has provided a full range of investment banking advisory services, including mergers and acquisitions, project finance, capital raising, and exceptional situations. David's customers have completed over 100 Healthcare Investment Banking transactions for financial institutions, healthcare institutional investors, and strategic partners since 2008.